MedTrace Logo

Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors

NCT04365023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2026-02-13

No results posted yet for this study

Summary

The purpose of this study is to analyse clinical data of well-differentiated grade 3 digestive neuroendocrine tumors. These rare tumors may have a different disease evolution, response to chemotherapy and prognostic.

Conditions

Interventions

DRUG

platinum chemotherapy

First line platinum chemotherapy

Sponsors & Collaborators

  • Ipsen

    collaborator INDUSTRY

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Romain CORIAT, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-02
Primary Completion
2023-05-25
Completion
2023-05-25

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04365023 on ClinicalTrials.gov